Cite
HARVARD Citation
Casadei Gardini, A. et al. (2016). Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC cancer. 16 (1), pp. 1-5. [Online].